N

Nightingale Health Oyj
OMXH:HEALTH

Watchlist Manager
Nightingale Health Oyj
OMXH:HEALTH
Watchlist
Price: 2.77 EUR 1.09%
Market Cap: 167.1m EUR
Have any thoughts about
Nightingale Health Oyj?
Write Note
Section:
 

Relative Value

The Relative Value of one HEALTH stock under the Base Case scenario is 1.08 EUR. Compared to the current market price of 2.77 EUR, Nightingale Health Oyj is Overvalued by 61%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HEALTH Relative Value
Base Case
1.08 EUR
Overvaluation 61%
Relative Value
Price
N
Worst Case
Base Case
Best Case

Valuation Multiples

37.9
P/S
P/S
Price to Sales
37.9
vs History
40
vs Industry
5
Median 3Y
30.1
Median 5Y
30.1
Industry
2.3
Forward
20.5
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-5.8
Median 5Y
-7
Industry
23.1
Forward
-10
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-13.8
Median 5Y
-14.6
Industry
14.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-6.2
Median 5Y
-6.2
Industry
20.1
More Details
2
P/B
P/B
Price to Book Value
2
vs History
21
vs Industry
54
Median 3Y
0.9
Median 5Y
1
Industry
2.2
More Details
23
EV/S
EV/S
Enterprise Value to Sales
23
vs History
25
vs Industry
9
Median 3Y
5.4
Median 5Y
5.4
Industry
2.4
Forward
12.4
More Details
34.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
34.5
vs History
25
vs Industry
9
Median 3Y
7.3
Median 5Y
7.3
Industry
5
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
-2.4
Industry
12.7
Forward
-9.9
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-1
Median 5Y
-1.7
Industry
17.1
Forward
-5.8
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-1.9
Median 5Y
-4.4
Industry
14
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-1.6
Median 5Y
-3.8
Industry
18
More Details
4.9
EV/IC
EV/IC
Enterprise Value to IC
4.9
vs History
21
vs Industry
32
Median 3Y
0.5
Median 5Y
0.7
Industry
1.9
More Details

Multiples Across Competitors

HEALTH Competitors Multiples
Nightingale Health Oyj Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FI
Nightingale Health Oyj
OMXH:HEALTH
165.3m EUR 37.9 -9.5 -9.6 -5.4
US
Cigna Corp
NYSE:CI
78.7B USD 0.3 25.9 8.1 10.4
US
Cigna Group
XMUN:CGN
75.6B EUR 0.3 25.9 8.1 10.4
US
CVS Health Corp
NYSE:CVS
56.5B USD 0.2 11.3 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
25.8B EUR 1.3 48.1 11.2 25.8
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.8B EUR 0.9 -49 9.3 18.9
US
Laboratory Corporation of America Holdings
NYSE:LH
19.3B USD 1.5 44.4 13.2 20.5
US
Quest Diagnostics Inc
NYSE:DGX
17.1B USD 1.8 20.5 12.3 16.7
US
R1 RCM Inc
NASDAQ:RCM
16.9B USD 6.9 -275.9 36.7 94.9
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
12.8B EUR 0.7 24.1 7 16.3
US
DaVita Inc
NYSE:DVA
12.9B USD 1 15.5 8 11.2
P/E Multiple
Earnings Growth P/E to Growth
FI
N
Nightingale Health Oyj
OMXH:HEALTH
Average P/E: 27
Negative Multiple: -9.5 		N/A N/A
US
Cigna Corp
NYSE:CI
25.9
96%
0.3
US
C
Cigna Group
XMUN:CGN
25.9
96%
0.3
US
CVS Health Corp
NYSE:CVS
11.3
8%
1.4
DE
Fresenius Medical Care AG
XMUN:FME
48.1
127%
0.4
DE
Fresenius SE & Co KGaA
XETRA:FRE
Negative Multiple: -49 N/A N/A
US
Laboratory Corporation of America Holdings
NYSE:LH
44.4
263%
0.2
US
Quest Diagnostics Inc
NYSE:DGX
20.5
41%
0.5
US
R1 RCM Inc
NASDAQ:RCM
Negative Multiple: -275.9
4 308%
N/A
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
24.1
127%
0.2
US
DaVita Inc
NYSE:DVA
15.5
61%
0.3

See Also

Summary
HEALTH intrinsic value, competitors valuation, and company profile.
DCF Valuation
HEALTH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HEALTH stock valuation using valuation multiples.
Wall Street Estimates
HEALTH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HEALTH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.